ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end technology platform LifeSphere announced a top 5 pharmaceutical research and development company has recruited LifeSphere IDMP to identify issues, overcome challenges, and achieve readiness and compliance regarding the Identification of Medicinal Products (IDMP) standards. The selection of LifeSphere IDMP marks an added solution to the pharma company’s LifeSphere technology stack, which also includes LifeSphere MultiVigilance, the industry’s leading safety case processing software.
Notably, the company is a US based biopharmaceutical leader with significant global operations, highlighting the relevance of IDMP compliance for pharma, biotech, and medical device companies even if their operations are based outside of the EU-specific regulation.
“Today, teams are working collaboratively at a global scale, proving that country-specific compliance standards are now applicable for all teams, regardless of the location of their headquarters,” shares Pat Jenakanandhini, Chief Product Officer at ArisGlobal. “IDMP should be considered a framework for investing in processes and technology to not only achieve compliance in the EU, but to maintain it, while also addressing the end-to-end processes throughout the regulatory lifecycle from a global perspective.”
Recommended AI News: Godrej & Boyce Partners With Digital Catapult to Develop Industrial Net-Zero Solutions
As a secure validated cloud solution, LifeSphere IDMP adapts over time to support the regulatory journey through continued xEVMPD compliance, multiple phases of IDMP compliance, UDI, and beyond. LifeSphere IDMP is a simple-to-use, ISO IDMP cloud application that specifically addresses the challenges of implementing Identification of Medicinal Products (IDMP) standards. With LifeSphere IDMP, life sciences companies can achieve compliance with xEVMPD, IDMP, UDI, SPL, and other standards, and collect data in an ISO IDMP-compliant fashion.
The news comes following regulatory analyst recognition for LifeSphere IDMP by Gens & Associates as the most-ready technology for pharmaceutical, biotech, and medical device companies, among others. This week, ArisGlobal presented at DIA RSIDM on global organization readiness for IDMP.
Recommended AI News: Airtel Deploys Oracle Fusion Cloud Applications to Accelerate Digital Transformation Across Its Supply Chain and Finance Processes
[To share your insights with us, please write to admin@websitehost.review]
TL;DR The global data center immersion cooling market is projected to expand from USD 1.7…
TL;DR Floating data center site selection is a system design decision rather than a simple…
Although many data center operators remain optimistic about the use of AI tools in operations,…
TL;DR Plant validation does not equal rack validation: Using a temporary load to walk a…
TL;DR Driven by the rapid growth of AI, cloud computing, high-performance computing (HPC), and edge…
TL;DR Cooling accounts for a significant share of a data center’s total energy draw, so…